Cell Fractionation Kit - Standard (ab109719)
Key features and details
- Assay type: Direct
Overview
-
Product name
Cell Fractionation Kit - Standard
See all Cell Fractionation kits -
Assay type
Direct -
Product overview
Abcam's Cell Fractionation Kit (Standard) allows for the rapid and simple preparation of mitochondrial, cytoplasmic and nuclear containing fractions from cultured cells from mammals and other species.
The Cell Fractionation Kit is designed to produce highly enriched fractions that allow for the monitoring of proteins of interest through various cellular compartments. It is not designed to produce purified cellular fractions.
This kit does not require mechanical disruption of the sample. This is important as mechanical disruption can disrupt mitochondrial membranes, causing the biologically-irrelevant release of proteins. This kit is particularly useful in studying apoptosis and the movement of pro-apoptotic proteins such as cytochrome c.
Sufficient materials are provided for fractionation of 1 x108 cells or for preparation of 40 samples, each corresponding to one 100 mm plate at 2.5 x 106 cells/plate.
A companion product is also available which allows for the fractionation of cells grown in 96-well plates: Cell Fractionation Kit HT (ab109718).
-
Notes
Properties
-
Storage instructions
Please refer to protocols. -
Components 1 kit 5X SDS Sample Buffer 1 x 10ml Buffer A 2x concentrate 1 x 175ml Detergent I 1 x 25µl Detergent II 1 x 1ml -
Research areas
-
Alternative names
- MS862
Associated products
-
Related Products
Images
-
Analysis of fractions by Western blot with a plasma membrane antibody cocktail.
Samples were loaded as follows from left to right: (1) Marker, (2) whole cell lysate, (3) cytosolic fraction lysate, (4) membrane fraction lysate and (5) nuclear fraction lysate. Membrane was blotted with a Plasma Membrane Fractionation WB cocktail ab140365 containing anti-Sodium Potassium ATPase antibody (110 kDa), anti-GAPDH antibody (37 kDa) and anti-Histone H3 (di methyl K9) antibody.
-
Western blot of cytoplasmic, mitchondrial and nuclear fractionsCytosolic (C), mitochondrial (M) and nuclear (N) fractions of HepG2 cells were prepared as described in the Protocol. Fractions were analyzed by Western blotting using Abcam's ApoTrack™ Cytochrome c Apoptosis WB Antibody Cocktail (ab110415) containing antibodies against mitochondrial matrix (pyruvate dehydrogenase subunit E1α, PDH E1α), mitochondrial inner membrane (F1-ATPase α), mitochondrial intermembrane space (cytochrome c) and cytosolic (glyceraldehyde-3-phosphate dehydrogenase, GAPDH) markers as well as with antibodies against additional mitochondrial matrix (Hsp70) and nuclear (poly (ADP-ribose) polymerase, PARP and SP1) markers, followed by appropriate HRP-conjugated goat secondary antibodies and ECL detection.
-
Western blotIn this experiment, apoptosis was induced in Jurkat, HeLa and 143B osteosarcoma cells by treatment with staurosporine or in Jurkat cells by FAS. Mitochondrial and cytoplasmic fractions were isolated (using ab109719) and probed using ab110415. As is clear from the gels, cytochrome c has translocated partially in FAS-induced cells and STS-treated osteosarcoma cells, and almost completely in STS-treated Jurkat and HeLa cells. The three control targets allow for verification of the "cleanness" of the cell fractionation.
Datasheets and documents
-
SDS download
-
Datasheet download
References (82)
ab109719 has been referenced in 82 publications.
- Yeh CW et al. The C-degron pathway eliminates mislocalized proteins and products of deubiquitinating enzymes. EMBO J 40:e105846 (2021). PubMed: 33469951
- Aoto K et al. ATP6V0A1 encoding the a1-subunit of the V0 domain of vacuolar H+-ATPases is essential for brain development in humans and mice. Nat Commun 12:2107 (2021). PubMed: 33833240
- Fang X et al. The HMGB1-AGER-STING1 pathway mediates the sterile inflammatory response to alkaliptosis. Biochem Biophys Res Commun 560:165-171 (2021). PubMed: 33992959
- Duncan-Lewis C et al. Cytoplasmic mRNA decay represses RNA polymerase II transcription during early apoptosis. Elife 10:N/A (2021). PubMed: 34085923
- Lenis-Rojas OA et al. Evaluation of the In Vitro and In Vivo Efficacy of Ruthenium Polypyridyl Compounds against Breast Cancer. Int J Mol Sci 22:N/A (2021). PubMed: 34445620